IL6 and neoplasm: Ganoderma lucidum contains both polysaccharides and triterpenoids, with organic solvent extracts showing direct cytotoxicity through IL-6/IL-8 suppression [67], commercial extracts inhibiting tumor growth via mechanistic target of rapamycin (mTOR) pathway modulation [68], and multiple immunomodulatory mechanisms [69].